Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

doi:10.1007/BF00665801

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Breast cancer research and treatment - 1 Jan 1993

Encarnación C A, Ciocca D R, McGuire W L, Clark G M, Fuqua S A, Osborne C K

Abstract excerpt

Estrogen (ER) and progesterone receptor (PgR) positive breast tumors often respond to tamoxifen, but ultimately progress as they become tamoxifen resistant. An accurate assessment of receptor status in specimens from tamoxifen-resistant patients could help to understand potential mechanisms of re...

Topics

Adult
Aged
Aged, 80 and over
Breast Neoplasms
Drug Resistance
Female
Humans
Immunohistochemistry
Ligands
Middle Aged
Neoplasms, Hormone-Dependent
Phenotype
Postmenopause
Receptors, Estrogen
Receptors, Progesterone
Tamoxifen

Source

Open in PubMed

Identifiers

PMID: 8251648
DOI: 10.1007/BF00665801

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8251648-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics